Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelos Kanavos

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Tumori|December 16, 2006
Selected hypoxic stop-flow perfusions: indication and limitsStefano Guadagni, Evangelos Kanavos, Mario Schietroma, et al.
In Vivo (Athens, Greece)|January 6, 2007
Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trialStefano Guadagni, Marco Clementi, Marco Valenti, et al.
In Vivo (Athens, Greece)|May 21, 2009
Thoracic stop-flow perfusion for refractory lymphoma: a phase I-II evaluation trialCristina Ruscitti, Stefano Guadagni, Filippo Russo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Tumori|December 16, 2006
Selected hypoxic stop-flow perfusions: indication and limitsStefano Guadagni, Evangelos Kanavos, Mario Schietroma, et al.
In Vivo (Athens, Greece)|January 6, 2007
Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trialStefano Guadagni, Marco Clementi, Marco Valenti, et al.
In Vivo (Athens, Greece)|May 21, 2009
Thoracic stop-flow perfusion for refractory lymphoma: a phase I-II evaluation trialCristina Ruscitti, Stefano Guadagni, Filippo Russo, et al.
Pageof 1